Zongjun Yu
Overview
Explore the profile of Zongjun Yu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hong Y, Yu Z, Zhou Q, Chen C, Hao Y, Wang Z, et al.
Nat Commun
. 2024 Aug;
15(1):6652.
PMID: 39103368
Nicotinamide adenine dinucleotide (NAD) is a redox cofactor and signal central to cell metabolisms. Disrupting NAD homeostasis in plant alters growth and stress resistance, yet the underlying mechanisms remain largely...
2.
Mu J, Xue C, Fu L, Yu Z, Nie M, Wu M, et al.
Nat Commun
. 2023 Apr;
14(1):1978.
PMID: 37031211
Dysregulation of polyamine homeostasis strongly associates with human diseases. ATP13A2, which is mutated in juvenile-onset Parkinson's disease and autosomal recessive spastic paraplegia 78, is a transporter with a critical role...
3.
Xie Y, Zhu Y, Wang N, Luo M, Ota T, Guo R, et al.
Proc Natl Acad Sci U S A
. 2022 Dec;
119(49):e2209256119.
PMID: 36454752
Auxin inactivation is critical for plant growth and development. To develop plant growth regulators functioning in auxin inactivation pathway, we performed a phenotype-based chemical screen in Arabidopsis and identified a...
4.
Luo F, Yu Z, Zhou Q, Huang A
Metabolites
. 2022 Jan;
12(1).
PMID: 35050197
Plants produce numerous structurally and functionally diverse signaling metabolites, yet only relatively small fractions of which have been discovered. Multi-omics has greatly expedited the discovery as evidenced by increasing recent...
5.
Zhao X, Huang W, Li X, Lin R, Li Q, Wu J, et al.
Eur J Pharm Biopharm
. 2021 Jun;
166:94-102.
PMID: 34118437
Vascular embolization is a well-known therapeutic treatment against hepatocellular carcinoma. However, existing embolic agents require complex synthesis, toxic organic solvents and sometimes produce only low yields. In this study, a...
6.
Du L, Huang Y, Zhang Q, Zhou Y, Huang J, Yan L, et al.
Acta Biomater
. 2019 Mar;
88:370-382.
PMID: 30822552
Transcatheter arterial chemoembolization (TACE) is well known as an effective treatment for inoperable hepatocellular carcinoma (HCC). In this study, a novel embolic agent of ion-exchange poly(hydroxyethyl methacrylate-acrylic acid) microspheres (HAMs)...